HSBC Downgrades Amgen (AMGN) to Hold

September 10, 2026 3:21 AM EDT Send to a Friend
HSBC analyst Morten Herholdt downgraded Amgen (NASDAQ: AMGN) from Buy to Hold with a price target of $425.00 (from $445.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login